U.S. Biofilms Treatment Market – Industry Trends and Forecast to 2030

1. U.S. Biofilms Treatment Market – Industry Trends and Forecast to 2030 The growing number of wounds and hospital-acquired infections in the healthcare industry has increased the demand for biofilm treatment. Biofilm treatment is required to prevent contamination because implanted devices such as catheters and pacemakers are the primary sites for biofilm growth. According to the survey, biofilms are present in 60% to 70% of chronic wounds. This factor is expected to accelerate market growth. Data Bridge Market Research analyses that the biofilms treatment market which is USD 4.70 billion in 2022, is expected to reach USD 8.20 billion by 2030, at a CAGR of 7.2% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. https://www.databridgemarketresearch.com/reports/us-biofilms-treatment-market

2. Report Description Market Definition A "biofilm" is a group of microorganisms that live on various surfaces. The microorganisms that cause a biofilm to form are bacteria, protists, and fungi. Biofilms can be seen on animal tissues, pacemakers, implanted medical equipment such as catheters, and plant tissues. Biofilms can form on the earth's surface, in groundwater, on minerals, or on metals. https://www.databridgemarketresearch.com/reports/us-biofilms-treatment-market Drivers Rise in Traumatic cases The market is expanding due to an increase in traumatic injuries such as burns and car accidents. According to the WHO, approximately 1,000,000 Indians suffer from severe to moderate burn injuries each year in 2019. This factor is expected to boost market growth. Furthermore, according to the National Center for Biotechnology Information (NCBI), the countries with the highest incidences of burn injuries in 2018 were the United Kingdom, the Netherlands, Bulgaria, China, India, Australia, and Finland. According to a 2017 American Association for the Surgery of Trauma survey, approximately 1.2 million people die every day, with road accidents accounting for 3,342 deaths. These are some of the factors are likely to have an impact on market growth. Growing number of wounds and hospital-acquired infections The growing number of wounds and hospital-acquired infections has increased the demand for biofilm in the healthcare industry. Biofilm treatment is required to prevent contamination because implanted devices such as catheters and pacemakers are primary sites for biofilm growth. According to the survey, biofilms are present in approximately 60% to 70% of chronic wounds. This factor is expected to hasten market growth.

3. Market Overview Restraints/Challenges High cost of treatment The rising treatment costs and low penetration rate of wound care products will slow market growth. The market will be challenged by a lack of skilled professionals and a lack of healthcare infrastructure in developing economies. This biofilms treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the biofilms treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. Recent Development In 2020, ConvaTec announced the release of ConvaMax, that aids in the management of highly draining wounds such as leg ulcers, surgical wounds, and diabetic foot ulcers. In 2020, Next Science Limited signed a partnership agreement with 3M for the exclusive distribution of BlastX, a gel used to treat biofilms formed over wounds. This distribution agreement assisted the company in increasing revenue by improving its distribution capabilities. https://www.databridgemarketresearch.com/reports/us-biofilms-treatment-market

4. Key Players • Some of the major players operating in the biofilms treatment market are: • Smith+Nephew (U.K.) • MiMedx (U.S.) • ConvaTec Group plc (U.K.) • Coloplast Group (Denmark) • Mölnlycke Healthcare AB (Sweden) • Organogenesis Inc. (U.S.) • Integra LifeSciences (U.S.) • B. Braun SE (Germany) • PAUL HARTMANN AG (Germany) • Medline Industries Inc. (U.K.) • Acelity (U.S.) • Misonix (U.S.) • Zimmer Biomet (U.S.) • Kerecis (Iceland) • Welcare Industries S.p.A (Italy) • https://www.databridgemarketresearch.com/reports/us-biofilms-treatment-market

5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Contact Us:- Data Bridge Market Research US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email:- corporatesales@databridgemarketresearch.com